Mereo BioPharma (MREO) Interest Expenses (2023 - 2026)
Mereo BioPharma (MREO) reported Interest Expenses of $20000.0 for Q1 2026, down 88.89% year-over-year from $180000.0 in Q1 2025, and down 13.04% quarter-over-quarter from $23000.0 in Q4 2025.
Mereo BioPharma (MREO) Interest Expenses (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has 4 years of Interest Expenses data on file, last reported at $20000.0 in Q1 2026.
- Interest Expenses for Q1 2026 came in at $20000.0, down 88.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $95000.0 (down 92.33% YoY), and the FY2025 annual result was $255000.0, down 81.39% from the prior year.
- Interest Expenses retreated to $20000.0 in Q1 2026 per MREO's latest filing, from $23000.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $1.0 million in Q2 2023 and troughed at $20000.0 in Q1 2026.
- A 4-year average of $348153.8 and a median of $331000.0 in 2024 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2024 and 2025: Interest Expenses gained 6.23% in 2024, then sank 93.87% in 2025.
- A 4-year view of Interest Expenses shows it stood at $353000.0 in 2023, then climbed by 6.23% to $375000.0 in 2024, then slumped by 93.87% to $23000.0 in 2025, then fell by 13.04% to $20000.0 in 2026.
- Business Quant data shows MREO's Interest Expenses at $20000.0 in Q1 2026, $23000.0 in Q4 2025, and $28000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Mereo BioPharma | 252.49 Mn | 252.49 Mn | - | 20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,000.00 |
| Mar 31, 2026 | 20,000.00 |
| Dec 31, 2025 | 23,000.00 |
| Dec 31, 2025 | 23,000.00 |
| Sep 30, 2025 | 28,000.00 |
| Sep 30, 2025 | 28,000.00 |
| Jun 30, 2025 | 24,000.00 |
| Jun 30, 2025 | 24,000.00 |
| Mar 31, 2025 | 180,000.00 |
| Mar 31, 2025 | 180,000.00 |
| Dec 31, 2024 | 375,000.00 |
| Dec 31, 2024 | 375,000.00 |
| Sep 30, 2024 | 353,000.00 |
| Sep 30, 2024 | 353,000.00 |
| Jun 30, 2024 | 331,000.00 |
| Jun 30, 2024 | 331,000.00 |
| Mar 31, 2024 | 310,000.00 |
| Mar 31, 2024 | 310,000.00 |
| Dec 31, 2023 | 353,000.00 |
| Dec 31, 2023 | 353,000.00 |